| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Royalty Pharma plc
13D/A
RPRX · G7709Q104
|
18.7% |
8/17/2026
Event 8/13/2026
|
||||
| Legorreta G. Pablo | 18.7% | |||||
| Legorreta Investments, LLC | 7.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.